The medical electrodes market is expected to reach USD 732.4 Million by 2022 from USD 583.2 Million in 2017, at a CAGR of 4.7%.
The growth of the market is attributed to the increasing incidence of neurological and cardiovascular disorders, subsequent growth in diagnostic procedures, growing preference for home and ambulatory healthcare, and increasing investment in R&D. Growing need for early disease diagnosis, untapped emerging markets are expected to offer significant growth opportunities for manufacturers in the coming years.
Browse 70 Market Data Tables and 42 Figures spread through 147 Pages and in-depth TOC on "Medical Electrodes Market"
Cardiology to dominate the market in 2017
Based on application, the Medical Electrodes Market is segmented into cardiology, neurophysiology, sleep disorders, intraoperative monitoring (IOM), and other applications.
In 2017, cardiology segment is expected to account for the largest share and to register the highest CAGR of the Medical Electrodes Market. This can be attributed to the increasing prevalence of cardiovascular diseases (CVD), growing geriatric population, rising cardiovascular health awareness, and technological innovations in diagnostics tools and monitoring techniques.
These factors drive the growth in the Medical Electrodes Market.
On the basis of technology, dry electrodes are projected to register the highest CAGR
By technology, the Medical Electrodes Market is segmented into dry electrodes, wet electrodes, and needle electrodes. Dry electrodes are expected to register the highest CAGR during the forecast period.
Dry electrodes measure biopotential signals without using any gel or adhesive. procedures involving the use of these electrodes do not require any skin preparation.
Various types of dry electrodes have been introduced in the market to overcome the issues associated with wet electrodes. Moreover, this market segment is witnessing numerous technological advancements focused on developing products that provide high signal quality and better patient comfort.
These factors are expected to boost the demand for dry electrodes.
North America to dominate the market followed by Europe
In 2017, North America is expected to account for the largest share of the Medical Electrodes Market. The high growth of the North American market is attributed to the factors such as the high incidence of neurological and cardiovascular disorders, increasing demand for technologically advanced electrodes, growing adoption of non-invasive diagnostic electrodes and increasing awareness about the benefits of early disease diagnosis.
In 2017, Europe is expected to hold the second largest share of Medical Electrodes Market. Factors such as presence of a well-established healthcare industry, significant funding for life sciences and medical research, rising geriatric population, and increasing incidence of neurodegenerative and cardiovascular disorders in several European countries are expected to fuel the market growth in this region.
The medical electrodes market is highly competitive with the presence of several small and big players. Some of the major players in the market include 3M (US), Medtronic plc (Ireland), Ambu (US), Natus Medical Incorporated (US), Rhythmlink International, LLC (US), Koninklijke Philips N.V.
(Netherlands), Cognionics, Inc. (US), CONMED Corporation (US), Leonhard Lang GmbH (acquired by DCC plc), and Nihon Kohden Corporation (Japan).
The other players in this market include Compumedics Limited (Australia), General Electric Company (US), g.Tec Medical Engineering GmbH (Austria), Vermed (US), Vectracor (US), Neuro Therapeutics (US), Emotiv (US), BIONEN sas (Italy), Nikomed (US), NeuroWave Systems Inc. (US), Wearable Sensing (US), Orbital Research Inc.
(US), NeuroSky (US), ANT Neuro (Netherlands), and SOMNOmedics GmbH (Germany).
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...